1,000+ Opportunities

Find the right grant

Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.

This listing may be outdated. Verify details at the official source before applying.

Find similar grants

ActiveNational Science Foundation (NSF) · 2026

SBIR Phase II: Dense Nanolipid Fluids (DNLFs) for Delivery of Drugs with Poor Bioavailability: Synthesis, Manufacture, and Drug Properties

Quick Facts

Agency: National Science Foundation (NSF)
Funding: Up to $1,247,672
Deadline: Check Source
Status: Active
Eligibility: Small businesses specializing in pharmaceutical development.

About This Grant

SBIR Phase II: Dense Nanolipid Fluids (DNLFs) for Delivery of Drugs with Poor Bioavailability: Synthesis, Manufacture, and Drug Properties is sponsored by National Science Foundation (NSF). This opportunity supports mission-aligned projects and measurable outcomes.

View Original RFP

Get a weekly digest of new grants like this

A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.

Or search similar grants →

Official Opportunity Details

Extracted from the official opportunity page/RFP to help you evaluate fit faster.

National Science Foundation About * Explore the Map Link opens in a new tab Search content at National Science Foundation * Principal Investigators * **Postal address**Show on map1000 WESTGATE DR STE 150N * Principal Investigators(1) ### Current Congressional District * District n. 04 of Minnesota ### Congressional Districts at Award * District n. 04 of Minnesota ### Core Based Statistical Area (CBSA) * Minneapolis-St.

Paul-Bloomington, MN-WI ### SBIR Phase II: Dense Nanolipid Fluids (DNLFs) for Delivery of Drugs with Poor Bioavailability: Synthesis, Manufacture, and Drug Properties * Solid Lipid Nanoparticle 31% ### SBIR Phase I: Dense Nanolipid Fluids (DNLFs) for Delivery of Drugs with Poor Bioavailability: Synthesis, Manufacture, and Drug Properties ## Principal Investigators * [](https://www. facebook. com/sharer.

php? u=https://nsf. elsevierpure.

com/en/organisations/superior-nano-llc/%3Futm_source%3Dfacebook%26utm_medium%3Dsocial%26utm_campaign%3Dsharelink&p[summary]=Check+out+this+research+unit+at+National+Science+Foundation%3A+SUPERIOR+NANO+LLC) * [](https://twitter. com/intent/tweet? url=https://nsf.

elsevierpure. com/en/organisations/superior-nano-llc/%3Futm_source%3Dtwitter%26utm_medium%3Dsocial%26utm_campaign%3Dsharelink&text=Check+out+this+research+unit+at+National+Science+Foundation%3A+SUPERIOR+NANO+LLC) * [](https://www. linkedin.

com/shareArticle? mini=true&url=https://nsf. elsevierpure.

com/en/organisations/superior-nano-llc/%3Futm_source%3Dlinkedin%26utm_medium%3Dsocial%26utm_campaign%3Dsharelink&summary=Check+out+this+research+unit+at+National+Science+Foundation%3A+SUPERIOR+NANO+LLC) * [](mailto:? subject=SUPERIOR%20NANO%20LLC&body=Check%20out%20this%20research%20unit%20at%20National%20Science%20Foundation%3A%20SUPERIOR%20NANO%20LLC%20|%20https://nsf. elsevierpure.

com/en/organisations/superior-nano-llc/? utm_source=email&utm_medium=email&utm_campaign=sharelink) Powered by Pure Link opens in a new tab, Scopus Link opens in a new tab&Elsevier Fingerprint Engine™ Link opens in a new tab National Science Foundation data protection policy Link opens in a new tab About web accessibility Link opens in a new tab Report vulnerability Link opens in a new tab [](https://nsf. elsevierpure.

com/en/organisations/superior-nano-llc/#)

Eligibility Requirements

Small businesses specializing in pharmaceutical development.

Frequently Asked Questions

Who can apply for SBIR Phase II: Dense Nanolipid Fluids (DNLFs) for Delivery of Drugs with Poor Bioavailability: Synthesis, Manufacture, and Drug Properties?

According to the current listing, eligibility includes: Small businesses specializing in pharmaceutical development. Confirm the full requirements in the official notice before applying.

How much funding does SBIR Phase II: Dense Nanolipid Fluids (DNLFs) for Delivery of Drugs with Poor Bioavailability: Synthesis, Manufacture, and Drug Properties offer?

The current listing shows up to $1,247,672. Verify award ceilings, matching requirements, and allowable costs in the official notice.

Who funds SBIR Phase II: Dense Nanolipid Fluids (DNLFs) for Delivery of Drugs with Poor Bioavailability: Synthesis, Manufacture, and Drug Properties?

SBIR Phase II: Dense Nanolipid Fluids (DNLFs) for Delivery of Drugs with Poor Bioavailability: Synthesis, Manufacture, and Drug Properties is funded by National Science Foundation (NSF). Verify program details on the funder's official page before applying.

How do I apply for SBIR Phase II: Dense Nanolipid Fluids (DNLFs) for Delivery of Drugs with Poor Bioavailability: Synthesis, Manufacture, and Drug Properties?

Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.

Funder Profile

Ready to start your proposal?

Granted drafts, reviews, and strengthens your grant application — saving weeks of work. Professional members win a grant in 12 months or get a full refund.

Browse More Grants

Backed by the Granted Guarantee

Similar Grants from Other Funders

U.S. Department of Transportation (DOT) Office of Small and Disadvantaged Business Utilization (OSDBU)

DiscoveredDeadline Passed

Small Business Transportation Technical Assistance Center (Region 3)

Small Business Transportation Technical Assistance Center (Region 3) is sponsored by U.S. Department of Transportation (DOT) Office of Small and Disadvantaged Business Utilization (OSDBU). Establish and operate a center to provide technical support to small businesses in Region 3, including outreach, training, and assistance in competing for DOT-funded transportation contracts.

$452,420Deadline: Aug 30, 2026 (passed)

National Science Foundation (NSF) Grant Writing Tips

NSF's TCUP Window Closes October 14. Only Three of Its Eight Tracks Are Actually Open

TCUP lists eight funding tracks and roughly $10.3M a year, but the October 14, 2026 deadline applies to only three of them — CHAI, Pre-TI, and TCUP Partnerships — and each carries a restriction that disqualifies most applicants. Here is the track-by-track math.

Read article

NSF's $100M AI Hubs Program Will Fund One Award Per State — Which Means the Real Competition Is Inside Your State, and It Ends November 4

NSF 26-513 makes roughly $100 million available for up to 10 State and Regional AI Infrastructure Hubs at $4M to $12M each over five years. One award per state or multi-state region. One proposal per organization. And NSF is not buying you GPUs — it funds the coordination, the workforce and the faculty training, while the compute has to come from partners you have to already have.

Read article

Eight Days Left to Obligate: NSF Is $1 Billion Behind, AHRQ Will Strand $160M, and a Judge Wants a Status Report by September 28

As of September 12, NSF had obligated $6.3 billion across 6,200 grants versus $8.1 billion and 8,600 last year. AHRQ has made 61 awards. Judge Allison Burroughs ordered the government to report by September 28 on whether IES will obligate $180 million before it expires. Here is what actually happens to the money on October 1 — and what it means for your FY2027 application.

Read article